Dr. Priscila Falagan Lotsch's lab at Auburn University studies how engineered nanomaterials (ENMs) affect human health, focusing specifically on their impact on mitochondria, the powerhouses of our cells. By investigating how these materials influence mitochondrial function under real-world exposure scenarios, the lab seeks to understand both the potential risks and benefits associated with nanotechnology. This research is crucial for developing safer nanotechnologies and therapeutic strategies to combat chronic diseases.